Quiltman it seems that most new drugs trying to have some impact...

Quiltman it seems that most new drugs trying to have some impact in the Neurological space seem to have Autophagy front and centre on their hit list.

PAA with Monepantel have shown we have Autophagy with the added bonus of no side effects.

The FDA have listed the highlighted Diseases together, I am by no means qualified in the scientific or medical field but with a little Googling they all appear to have something in common that is a break down proteins which are short lived building blocks with in the cells and neurons of the body.

The Division of Neurology I (DNI) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of neurodegenerative disorders, movement disorders, and neuromuscular disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, muscular dystrophy, amyotrophic lateral sclerosis, and spasticity.

https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-neuroscience-division-neurology-i

Good luck to all and DYOR